{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T07:21:05Z","timestamp":1787469665516,"version":"build-2736575974"},"reference-count":7,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anti-f is produced by exposure to the compound antigen ce (f) on red blood cells (RBCs), expressed when both c and e are present on the same protein (\n                    <jats:italic>cis<\/jats:italic>\n                    position). Although anti-f was discovered in 1953, there are few cases reported worldwide because the presence of anti-f is often masked by anti-c or anti-e and is not generally found as a single antibody. In the present case, anti-f was identified by using three-cell screening and 11-cell identification panels. The identification of anti-f was further supported by additional testing, including (1) Rh antigen typing; (2) antibody identification panels (enzyme-treated panel [ficin] and an in-house\u2013constructed Rh panel); (3) look-back and phenotyping of donor RBC units, which were responsible for alloimmunization; and (4) molecular testing of the patient\u2019s RBCs.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2024-008","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T03:23:30Z","timestamp":1719199410000},"page":"54-57","source":"Crossref","is-referenced-by-count":0,"title":["A patient with anti-f in India identified by extensive immunohematologic workup"],"prefix":"10.2478","volume":"40","author":[{"given":"Sunil","family":"Golia","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity , Gurgaon , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samruddhi","family":"Pawar","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity , Gurgaon , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem K.","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity , Gurgaon , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geet","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity , Gurgaon , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity , Gurgaon , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Medanta \u2013 The Medicity , Gurgaon , India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"2026082306580434976_j_immunohematology-2024-008_ref_001","unstructured":"Harmening DM. The RH blood group system. In: Modern blood banking and transfusion practices. 7th ed. Philadelphia, PA: F.A. Davis Company; 2019:165."},{"key":"2026082306580434976_j_immunohematology-2024-008_ref_002","doi-asserted-by":"crossref","unstructured":"Chow PK, Tsoi WC. Antibody against compound antigen ce (f). J Hong Kong Inst Med Lab Sci 1997;98:19\u201321.","DOI":"10.2307\/303762"},{"key":"2026082306580434976_j_immunohematology-2024-008_ref_003","doi-asserted-by":"crossref","unstructured":"Jator EK, Pedde E. Anti-f in a 24-year-old male: a case study. Clin Lab Sci 2010;23:68\u201371.","DOI":"10.29074\/ascls.23.2.68"},{"key":"2026082306580434976_j_immunohematology-2024-008_ref_004","doi-asserted-by":"crossref","unstructured":"Nakamura Y, Ohsawa T, Furuta Y, Tokida M, Ichikawa K. Successful identification of anti-F alloantibody in a non-transfused male patient employing ID-micro typing system gel cards. J Blood Disord Transfus 2015;6:2.","DOI":"10.4172\/2155-9864.1000320"},{"key":"2026082306580434976_j_immunohematology-2024-008_ref_005","doi-asserted-by":"crossref","unstructured":"Nah H, Shin S, Kim S, Lee E, Kim HO. A case report of anti-f (ce) identified in a patient with pancreatic cancer. Korean J Blood Transfus 2016;27:174\u201382.","DOI":"10.17945\/kjbt.2016.27.2.174"},{"key":"2026082306580434976_j_immunohematology-2024-008_ref_006","doi-asserted-by":"crossref","unstructured":"Alharbi A, Batarfi K, Kiseo PD, Saleh JF, Shareefi AA, Nourah AH. Detection of anti-f on a 51-year-old Saudi female. J Applied Hematol 2020;11:199.","DOI":"10.4103\/joah.joah_59_20"},{"key":"2026082306580434976_j_immunohematology-2024-008_ref_007","doi-asserted-by":"crossref","unstructured":"Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. Amsterdam: Boston Elsevier\/Academic Press, 2004.","DOI":"10.1016\/B978-012586585-2\/50027-5"}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2024-008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T06:58:08Z","timestamp":1787468288000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2024-008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":7,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6,24]]},"published-print":{"date-parts":[[2024,6,1]]}},"alternative-id":["10.2478\/immunohematology-2024-008"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2024-008","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}